{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T12:27:41Z","timestamp":1765024061624,"version":"3.46.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jbo.2025.100709","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T15:18:07Z","timestamp":1756826287000},"page":"100709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Modified OPTIModel with oligometastatic disease for the prediction of overall survival of patients with renal cell cancer and symptomatic long bone metastases"],"prefix":"10.1016","volume":"55","author":[{"given":"E.W.","family":"Dootjes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Willeumier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.W.P.G.","family":"van der Wal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J.P.","family":"van der Wal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"van der Zwaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Leithner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.A.M.","family":"van der Veldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fiocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.L.M.","family":"van Broekhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.M.","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2025.100709_b0005","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejca.2021.07.039","article-title":"The European cancer in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers","volume":"157","author":"Dyba","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jbo.2025.100709_b0010","article-title":"Renal cell carcinoma: an overview of the epidemiology, diagnosis and treatment","volume":"39(3):2022-vol3","author":"Bahadoram","year":"2022","journal-title":"G. Ital. Nefrol."},{"issue":"4","key":"10.1016\/j.jbo.2025.100709_b0015","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/annonc\/mdr362","article-title":"Distribution of metastatic sites in renal cell carcinoma: a population-based analysis","volume":"23","author":"Bianchi","year":"2012","journal-title":"Ann. Oncol."},{"issue":"25","key":"10.1016\/j.jbo.2025.100709_b0020","first-page":"000085","article-title":"Mitigating the risk of skeletal events in metastatic renal cell carcinoma","volume":"S2405\u20134569","author":"Chen","year":"2025","journal-title":"Eur. Urol. Focus"},{"issue":"11","key":"10.1016\/j.jbo.2025.100709_b0025","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1080\/14737140.2018.1520097","article-title":"Treating patients with renal cell carcinoma and bone metastases","volume":"18","author":"Guida","year":"2018","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"5","key":"10.1016\/j.jbo.2025.100709_b0030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1302\/2058-5241.1.000008","article-title":"Treatment of pathological fractures of the long bones","volume":"1","author":"Willeumier","year":"2016","journal-title":"EFORT Open Rev."},{"issue":"2","key":"10.1016\/j.jbo.2025.100709_b0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/17453679508995508","article-title":"Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients","volume":"66","author":"Bauer","year":"1995","journal-title":"Acta Orthop. Scand."},{"issue":"5","key":"10.1016\/j.jbo.2025.100709_b0040","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1302\/0301-620X.87B5.15185","article-title":"Prognostic factors and a scoring system for patients with skeletal metastasis","volume":"87","author":"Katagiri","year":"2005","journal-title":"J. Bone Joint Surg. Br."},{"key":"10.1016\/j.jbo.2025.100709_b0045","first-page":"223","article-title":"Clinical evaluation of anticancer drugs: cancer chemotherapy","volume":"2","author":"Karnofsky","year":"1967","journal-title":"Gann Monogr."},{"issue":"3","key":"10.1016\/j.jbo.2025.100709_b0050","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2106\/JBJS.16.01514","article-title":"An easy-to-use prognostic model for survival estimation for patients with symptomatic long bone metastases","volume":"100","author":"Willeumier","year":"2018","journal-title":"J. Bone Joint Surg. Am."},{"issue":"4","key":"10.1016\/j.jbo.2025.100709_b0055","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1302\/0301-620X.99B4.BJJ-2016-0872.R1","article-title":"Epidermal growth factor receptor mutations should be considered as a prognostic factor for survival of patients with pathological fractures or painful bone metastases from non-small cell lung cancer","volume":"99-B","author":"Willeumier","year":"2017","journal-title":"Bone Joint J."},{"issue":"1","key":"10.1016\/j.jbo.2025.100709_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10585-014-9685-y","article-title":"Molecular phenotype is associated with survival in breast cancer patients with spinal bone metastases","volume":"32","author":"Bollen","year":"2015","journal-title":"Clin. Exp. Metastasis"},{"issue":"1","key":"10.1016\/j.jbo.2025.100709_b0065","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.jbo.2025.100709_b0070","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S1470-2045(12)70510-7","article-title":"Stereotactic body radiotherapy for oligometastases","volume":"14","author":"Tree","year":"2013","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.jbo.2025.100709_b0075","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrclinonc.2011.44","article-title":"Oligometastases revisited","volume":"8","author":"Weichselbaum","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jbo.2025.100709_b0080","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13014-014-0230-6","article-title":"Oligometastasis and oligo-recurrence: more than a mirage","volume":"9","author":"Huang","year":"2014","journal-title":"Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.jbo.2025.100709_b0085","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/cncr.23518","article-title":"Renal cell cancer stage migration: analysis of the National Cancer Data Base","volume":"113","author":"Kane","year":"2008","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.jbo.2025.100709_b0090","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10585-016-9805-y","article-title":"Prognostic significance of intensive local therapy to bone lesions in renal cell carcinoma patients with bone metastasis","volume":"33","author":"Fukushima","year":"2016","journal-title":"Clin. Exp. Metastasis"},{"issue":"4","key":"10.1016\/j.jbo.2025.100709_b0095","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control. Clin. Trials"},{"issue":"4","key":"10.1016\/j.jbo.2025.100709_b0100","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat. Med."},{"issue":"4","key":"10.1016\/j.jbo.2025.100709_b0105","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4048\/jbc.2015.18.4.371","article-title":"Metastasis-free interval is closely related to tumor characteristics and has prognostic value in breast cancer patients with distant relapse","volume":"18","author":"Kim","year":"2015","journal-title":"J. Breast Cancer"},{"issue":"1","key":"10.1016\/j.jbo.2025.100709_b0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12885-017-3922-0","article-title":"Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States","volume":"18","author":"Hernandez","year":"2018","journal-title":"BMC Cancer"},{"issue":"18","key":"10.1016\/j.jbo.2025.100709_b0115","doi-asserted-by":"crossref","first-page":"26879","DOI":"10.18632\/oncotarget.8568","article-title":"Oligometastatic state predicts a outcome for renal cell carcinoma patients with bone metastasis under the treatment of sunitinib","volume":"7","author":"Lu","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.jbo.2025.100709_b0120","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s10147-011-0359-3","article-title":"Prognostic factors for patients with solitary bone metastasis","volume":"18","author":"Hoshi","year":"2013","journal-title":"Int. J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.jbo.2025.100709_b0125","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ejso.2015.04.008","article-title":"Survival and complications of skeletal reconstructions after surgical treatment of bony metastatic renal cell carcinoma","volume":"41","author":"Laitinen","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.jbo.2025.100709_b0130","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jso.23654","article-title":"Prognostic role of en-bloc resection and late onset of bone metastasis in patients with bone-seeking carcinomas of the kidney, breast, lung, and prostate: SSG study on 672 operated skeletal metastases","volume":"110","author":"Ratasvuori","year":"2014","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.jbo.2025.100709_b0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12253-009-9184-7","article-title":"Prognostic factors and survival of renal clear cell carcinoma patients with bone metastases","volume":"16","author":"Szendroi","year":"2010","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.jbo.2025.100709_b0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.blo.0000149820.65137.b4","article-title":"Solitary bony metastasis from renal cell carcinoma: significance of surgical treatment","volume":"431","author":"Fuchs","year":"2005","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"4","key":"10.1016\/j.jbo.2025.100709_b0145","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejso.2013.08.001","article-title":"Massive endoprosthetic replacement for bone metastases resulting from renal cell carcinoma: factors influencing patient survival","volume":"40","author":"Hwang","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.jbo.2025.100709_b0150","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.2106\/00004623-200708000-00018","article-title":"Patient survival after surgery for osseous metastases from renal cell carcinoma","volume":"89","author":"Lin","year":"2007","journal-title":"J. Bone Joint Surg. Am."},{"issue":"5","key":"10.1016\/j.jbo.2025.100709_b0155","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.euo.2019.05.007","article-title":"Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies","volume":"2","author":"Zaorsky","year":"2019","journal-title":"Eur. Urol. Oncol."},{"issue":"1","key":"10.1016\/j.jbo.2025.100709_b0160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bone.2010.09.008","article-title":"Skeletal complications and survival in renal cancer patients with bone metastases","volume":"48","author":"Woodward","year":"2011","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.jbo.2025.100709_b0165","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.clgc.2022.12.010","article-title":"Effect of bisphosphonates on skeletal related events in long bone metastases of renal cell carcinoma: a systematic review","volume":"21","author":"van Broekhoven","year":"2023","journal-title":"Clin. Genitourin. Cancer"},{"issue":"9","key":"10.1016\/j.jbo.2025.100709_b0170","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00259-019-04358-9","article-title":"Lesion detection by [89ZR]Zr-DFO-girentuximab and [18F]FDG-PET\/CT in patients with newly diagnosed metastatic renal cell carcinoma","volume":"46","author":"Verhoef","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"10","key":"10.1016\/j.jbo.2025.100709_b0175","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/annonc\/mdv289","article-title":"Prospective study evaluating the relative sensitivity of 18F-NaF PET\/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design","volume":"26","author":"Gerety","year":"2015","journal-title":"Ann. Oncol."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137425000508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137425000508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T12:24:44Z","timestamp":1765023884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137425000508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":35,"alternative-id":["S2212137425000508"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2025.100709","relation":{},"ISSN":["2212-1374"],"issn-type":[{"type":"print","value":"2212-1374"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modified OPTIModel with oligometastatic disease for the prediction of overall survival of patients with renal cell cancer and symptomatic long bone metastases","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2025.100709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100709"}}